Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans

European Journal of Pharmacology

Volumn 644, Issue 1-3, 2010, Pages 101-105

  Stoops, William W ^a,b   Lile, Joshua A ^a   Glaser, Paul E A ^a   Hays, Lon R ^a   Rush, Craig R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cocaine; Humans; Intranasal; Progressive ratio

Indexed keywords

COCAINE;

ADULT; ARTICLE; BEHAVIOR THERAPY; COCAINE DEPENDENCE; CONTROLLED STUDY; DECISION MAKING; EXPERIMENTAL STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PHYSIOLOGICAL PROCESS; PREDICTION; PRIORITY JOURNAL; REINFORCEMENT;

ADMINISTRATION, INTRANASAL; ADULT; CHOICE BEHAVIOR; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 77955770636     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.055     Document Type: Article

References (50)

1. Chen C.Y., Lin K.M. Health consequences of illegal drug use. Curr. Opin. Psychiatry 2009, 22:287-292.
2. Collins S.L., Evans S.M., Foltin R.W., Haney M. Intranasal cocaine in humans: effects of sex and menstrual cycle. Pharmacol. Biochem. Behav. 2007, 86:117-124.
3. Comer S.D., Ashworth J.B., Foltin R.W., Johanson C.E., Zacny J.P., Walsh S.L. The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend. 2008, 96:1-15.
4. Cregler L.L. Adverse health consequences of cocaine abuse. J. Natl. Med. Assoc. 1989, 81:27-38.
5. Donny E.C., Bigelow G.E., Walsh S.L. Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming. Psychopharmacology (Berl.) 2004, 172:316-323.
6. European Monitoring Centre for Drugs and Drug Addiction 2009 Annual report on the state of the drugs problem in Europe 2009, Publications Office of the European Union, Luxembourg.
7. Fischman M.W. The behavioral pharmacology of cocaine in humans. NIDA Res. Monogr. 1984, 50:72-91.
8. Fischman M.W., Schuster C.R. Cocaine self-administration in humans. Fed. Proc. 1982, 41:241-246.
9. Foltin R.W., Fischman M.W. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J. Pharmacol. Exp. Ther. 1991, 257:247-261.
10. Foltin R.W., Haney M. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol. Biochem. Behav. 2004, 78:93-101.
11. Foltin R.W., Fischman M.W., Pedroso J.J., Pearlson G.D. Repeated intranasal cocaine administration: lack of tolerance to pressor effects. Drug Alcohol Depend. 1988, 22:169-177.
12. Foltin R.W., Fischman M.W., Nestadt G., Stromberger H., Cornell E.E., Pearlson G.D. Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend. 1990, 26:145-154.
13. Gorelick D.A. Progression of dependence in male cocaine addicts. Am. J. Drug Alcohol Abuse 1992, 18:13-19.
14. Gossop M., Griffiths P., Powis B., Strang J. Cocaine: patterns of use, route of administration, and severity of dependence. Br. J. Psychiatry 1994, 164:660-664.
15. Haney M., Spealman R. Controversies in translational research: drug self-administration. Psychopharmacology (Berl.) 2008, 199:403-419.
16. Haney M., Foltin R.W., Fischman M.W. Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology (Berl.) 1998, 137:15-24.
17. Haney M., Hart C.L., Foltin R.W. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 2006, 31:1814-1821.
18. Hart C.L., Haney M., Collins E.D., Rubin E., Foltin R.W. Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend. 2007, 86:274-277.
19. Higgins S.T. The influence of alternative reinforcers on cocaine use and abuse: a brief review. Pharmacol. Biochem. Behav. 1997, 57:419-427.
20. Higgins S.T., Bickel W.K., Hughes J.R., Lynn M., Capeless M.A., Fenwick J.W. Effects of intranasal cocaine on human learning, performance and physiology. Psychopharmacology (Berl). 1990, 102:451-458.
21. Higgins S.T., Bickel W.K., Hughes J.R. Influence of an alternative reinforcer on human cocaine self-administration. Life Sci. 1994, 55:179-187.
22. Javaid J.I., Fischman M.W., Schuster C.R., Dekirmenjian H., Davis J.M. Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 1978, 202:227-228.
23. Katz J.L. Models of relative reinforcing efficacy of drugs and their predictive utility. Behav. Pharmacol. 1990, 1:283-301.
24. Lamb R.J., Preston K.L., Schindler C.W., Meisch R.A., Davis F., Katz J.L., Henningfield J.E., Goldberg S.R. The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J. Pharmacol. Exp. Ther. 1991, 259:1165-1173.
25. Lile J.A. Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment. Exp. Clin. Psychopharmacol. 2006, 14:20-33.
26. Lile J.A., Stoops W.W., Allen T.S., Glaser P.E., Hays L.R., Rush C.R. Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology (Berl.) 2004, 171:441-449.
27. Lile J.A., Ross J.T., Nader M.A. A comparison of the reinforcing efficacy of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug Alcohol Depend. 2005, 78:135-140.
28. Malcolm R., Kajdasz D.K., Herron J., Anton R.F., Brady K.T. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000, 60:161-168.
29. Oliveto A.H., Bickel W.K., Hughes J.R., Shea P.J., Higgins S.T., Fenwick J.W. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J. Pharmacol. Exp. Ther. 1992, 261:885-894.
30. Oliveto A.H., Rosen M.I., Woods S.W., Kosten T.R. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. J. Pharmacol. Exp. Ther. 1995, 272:231-241.
31. Prinzleve M., Haasen C., Zurhold H., Matali J.L., Bruguera E., Gerevich J., Bácskai E., Ryder N., Butler S., Manning V., Gossop M., Pezous A.M., Verster A., Camposeragna A., Andersson P., Olsson B., Primorac A., Fischer G., Güttinger F., Rehm J., Krausz M. Cocaine use in Europe-a multi-centre study: patterns of use in different groups. Eur. Addict. Res. 2004, 10:147-155.
32. Resnick R.B., Kestenbaum R.S., Schwartz L.K. Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science 1977, 195:696-698.
33. Richardson N.R., Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Meth. 1996, 66:1-11.
34. Rowlett J.K., Woolverton W.L. Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule. Psychopharmacology (Berl.) 1997, 133:363-371.
35. Rush C.R., Baker R.W., Wright K. Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis. Drug Alcohol Depend. 1999, 55:1-12.
36. Rush C.R., Stoops W.W., Hays L.R., Glaser P.E., Hays L.S. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J. Pharmacol. Exp. Ther. 2003, 306:195-204.
37. Rush C.R., Stoops W.W., Sevak R.J., Hays L.R. Cocaine choice in humans during d-amphetamine maintenance. J. Clin. Psychopharmacol. 2010, 30:152-159.
38. Selzer M.L. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am. J. Psychiatry 1971, 127:1653-1658.
39. Sevak, R.J., Stoops, W.W., Glaser, P.E.A., Hays, L.R., Rush, C.R., under review. Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule.
40. Skinner H.A. The drug abuse screening test. Addict. Behav. 1982, 7:363-371.
41. Sobel B.F., Sigmon S.C., Griffiths R.R. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers. Neuropsychopharmacology 2004, 29:991-1003.
42. Stoops W.W. Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules. Exp. Clin. Psychopharmacol. 2008, 16:503-512.
43. Stoops W.W., Blackburn J.W., Hudson D.A., Hays L.R., Rush C.R. Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. Drug Alcohol Depend. 2008, 92:282-285.
44. Stoops W.W., Lile J.A., Rush C.R. Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol. Biochem. Behav. 2010, 95:187-191.
45. Substance Abuse and Mental Health Services Administration The DASIS Report: Trends in Cocaine Treatment Admissions, by State: 1992-2002 2005, Office of Applied Studies, Rockville, MD, USA.
46. Substance Abuse and Mental Health Services Administration The DASIS Report: Cocaine Route of Administration Trends: 1995-2005 2007, Office of Applied Studies, Rockville, MD, USA.
47. Substance Abuse and Mental Health Services Administration Results from the 2008 National Survey on Drug Use and Health: National Findings 2009, Office of Applied Studies, Rockville, MD, USA.
48. van der Meer Sanchez Z., Nappo S.A. From the first drug to crack: the sequence of drugs taken in a group of users in the city of São Paulo. Subst. Use Misuse 2007, 42:177-188.
49. Volkow N.D., Wang G.J., Fischman M.W., Foltin R., Fowler J.S., Franceschi D., Franceschi M., Logan J., Gatley S.J., Wong C., Ding Y.S., Hitzemann R., Pappas N. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci. 2000, 67:1507-1515.
50. Walsh S.L., Donny E.C., Nuzzo P.A., Umbricht A., Bigelow G.E. Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory. Drug Alcohol Depend. 2010, 106:28-37.